Shares of Evotec SE (OTCMKTS:EVTCY – Get Free Report) crossed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $2.91 and traded as low as $2.75. Evotec shares last traded at $2.80, with a volume of 55,550 shares changing hands.
Evotec Trading Up 1.8%
The stock has a market capitalization of $941.13 million, a PE ratio of 6.95 and a beta of 0.98. The company has a current ratio of 2.57, a quick ratio of 2.50 and a debt-to-equity ratio of 0.53. The firm has a 50-day moving average price of $2.90 and a 200-day moving average price of $3.06.
Evotec Company Profile
Evotec SE is a Germany-based biotechnology company specializing in drug discovery alliance and development partnerships. Headquartered in Hamburg, the company collaborates with pharmaceutical and biotechnology firms to deliver integrated solutions across the drug discovery and development continuum. Its offerings span from target identification and validation to lead optimization, preclinical development and manufacturing support.
The company’s platform combines expertise in assay development, high-throughput screening, medicinal chemistry, in vivo pharmacology and safety assessment.
Further Reading
- Five stocks we like better than Evotec
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
